Glycosylation reaction
7 is crucial for the synthesis of complex glycoconjugates, including the nucleosides. Although there has been fairly significant advancement in the field of glycoconjugate synthesis, the efficiency of glycosidic bond formation in achieving high chemical yield, stereoselectivity and regioselectivity 8 still remains challenging. 9 The classical aspects of carbohydrate chemistry centers around the anomeric carbon where glycosidic bond formation takes place via glycosyl cation 10 and stereochemical outcome depends on attaching the aglycones to give either -or -glycosides. 11 We were interested in developing efficient glycosylation methods for the synthesis of glycoconjugates. 12 In continuation of our efforts to develop efficient glycosylation reactions, we designed an acetoxymethoxy leaving group at the anomeric centre and demonstrated its ability as glycosyl donor. 13 During our investigations, we found that when a glycosylation reaction was performed with O-nucleophiles, it resulted into O-glycosides, whereas N-nucleophiles afforded glycosyloxymethyl derivatives. 13, 14 The formation of glycosyloxymethyl derivatives was explained based on capturing the glycosyloxymethyl cation 'b' by Nnucleophiles such as nucleic acid bases (Scheme 1).
14 In order to confer generality to the concept developed for synthesis of novel nucleosides and to probe the reactivity of other glycosyl donors we report the activation of xylofuranosyl donor. Furthermore, given the medicinal importance of acylic nucleosides, synthesis of modified glycosyloxymethyl nucleosides may provide new therapeutic agents that can inhibit herpes simplex virus.
RESULTS AND DISCUSSION
The key substrate xylofuranosyl donor 4 was prepared starting from 1-O-acetyl-2,3,5-tri-Obenzoyl-/-D-xylofuranoside (1).
14 Compound 1 on reaction with propargyl alcohol and BF 3 .OEt 2 at room temperature gave 2-propynyl 2,3,5-tri-Obenzoyl--D-xylofuranoside (2) (Scheme 2). 15 Compound 2 on further reaction with a catalytic amount of Hg(OCOCF 3 ) 2 in acetone-H 2 O (2:1) at room temperature gave the corresponding 2-( o x o p r o p o x y ) -2 , 3 , 5 -t r i -O -b e n z o y l -² -Dxylofuranoside (3) . Baeyer-Villiger rearrangement of 3 with m-CPBA in CHCl 3 at room temperature gave 1-[ (2,3,5-tri-O-benzoyl--D-(xylofuranosyloxy) methyl]acetate (4) in 45% overall yield from compound 1. Compound 4 was characterized by 1 H NMR spectrum from the appearance of methylene protons at  5.40-5.48 (m, 2H), anomeric proton (H-1) at  5.50 as a singlet indicating the -anomeric configuration and by 13 C NMR from the appearance of methylene carbon at  85.1 and anomeric carbon (C-1) at  104.9.
Fig .1. Therapeutically important nucleoside analogues Scheme 1: Activation of acetoxymethoxy glycosyl donor
To envisage the concept, we first investigated the coupling reactions of xylofuranosyl donor 4 with pyrimidine bases 5-8. 16 Thus, coupling reaction of 4 with 5 in CHCl 3 and using activator SnCl 4 at room temperature gave 1-[ (2,3,5- In order to probe the reactivity of xylofuranosyl donor 4, we carefully studied the coupling reactions using organic Lewis acid, TMSOTf. Thus, coupling of 4 with 5, 6 by use of TMSOTf afforded the xylofuranosyloxymethyl pyrimidine nucleosides 9 and 12 exclusively. Formation of the corresponding natural nucleosides 10 and 13 were not observed. Coupling of 4 with 7 under similar conditions using TMSOTf showed poor selectivity. It resulted into the formation of xylofuranosyloxymethyl cytosine derivative 15 and natural nucleoside 16 in a ratio of 1.0:1.8. The formation of mixture of cytosine nucleosides may be due to the basicity of cytosine. Therefore, we protected cytosine as N 4 -bz-cytosine 8 and used for coupling with 4, which resulted in the formation of
in a ratio of 2.9:1.0. Similarly, coupling of 4 with 20 using TMSOTf as an activator gave xylofuranosyloxymethyl adenine 21 and natural nucleoside 22 in a ratio of 1.0:1.27. Coupling of 4 with 24 using TMSOTf gave oxymethyl guanine nucleosides 25, 26 and natural nucleoside 27, formation of 28 was not observed (Scheme 5). The ratio of natural nucleosides to oxymethyl guanine nucleosides was 1.0:14.0. Thus, synthesis of xylofuranosyloxymethyl nucleosides was achieved by coupling of xylofuranosyl donor 4 with nucleic acid bases similar to ribofuranosyl donor 14 . It was observed that the formation of glycosyloxymethyl nucleosides was in a higher ratio to natural nucleosides in case of ribofuranosyl donor when compared to xylofuranosyl donor during coupling reactions performed using SnCl 4 . This may be due to subtle difference in the reactivity of xylose donor to the ribose donor. There is no significant difference observed between ribose and xylose donors when activated by TMSOTf.
EXPERIMENTAL General

1
H NMR spectra were recorded using the following instruments: at 200 MHz on a Varian Gemini, at 300 MHz on a Bruker Avance; at 400 MHz on a Varian Unity; at 500 MHz on a Varian Inova, with tetramethyl silane as internal standard for solutions in CDCl 3 . J values are given Hz. 13 C NMR spectra were taken with a Varian Gemini (50 MHz), Bruker Avance (75 MHz) spectrometer with CDCl 3 as internal standard (C 77.0) for solutions in deuteriochloroform, DMSO-d6 (C 39.7) for solutions in deuteriodimethyl sulfoxide, dioxane (C 67.3) for solutions in D 2 O. Optical rotations were measured with a JASCO DIP-370 instrument. Melting points were determined by using FischerJohn's melting point apparatus and are uncorrected. IR spectra were taken with a Perkin-Elmer 1310 spectrometer. UV spectra were recorded on a Shimadzu UV 160A spectrometer. Organic solutions were dried over anhydrous Na 2 SO 4 .
2-Propynyl 2,3,5-tri-O-benzoyl-
.5 mmol) in dry CHCl 3 (300 mL) was added propargyl alcohol (4.2 mL, 71.4 mmol) and BF 3 .OEt 2 (9 mL, 71.4 mmol) at 0 o C. The reaction mixture was stirred at room temperature for 8 h. After completion of the reaction, anhydrous K 2 CO 3 (9.0 g) was added, stirred for a further 30 min., filtered, and the residue was washed with CHCl 3 (75 mL). The filtrate was transferred to a separating funnel, washed with water (2x150 mL) and brine (150 mL). The organic phase was separated, dried (Na 2 SO 4 ) and concentrated to obtain a residue. The residue was chromatographed [SiO 2 ; 60-120 mesh; hexaneethyl acetate (9:1)] to isolate the title compound (3.16 g, 7 .60 mmol). The reaction mixture was stirred at room temperature for 6 h. After completion of the reaction, acetone was evaporated; the resulting residue was dissolved in ethyl acetate (300 mL), washed with 10% aq. KI solution (2x150 mL), 20% aq. hypo solution (2x150 mL) and brine (150 mL). The organic layer was separated, dried over Na 2 SO 4 and concentrated to obtain the title compound 3 as syrup (18.2 
methyl] acetate (4)
To a solution of 3 (17.5g, 33.7 mmol) in dry CHCl 3 (175 mL) was added m-CPBA (14.0 g, 81.1 mmol). The reaction mixture was stirred at room temperature for 14 h. After completion of the reaction, the reaction mixture was diluted with CHCl 3 (150 mL), washed with saturated aq. NaHCO 3 solution (150 mLx3, water (150 mL), brine (150 mL) and dried (Na 2 SO 4 ). The solvent was concentrated to give a residue which was purified by silica gel chromatography [SiO 2 ; 60-120 mesh; hexane:ethyl acetate (9:1)] to obtain the title compound 4 as a solid The reaction mixture was stirred at room temperature for 4-18 h or reflux temperature for 1-6 h, progress of the reaction was monitored by TLC. After completion of the reaction it was neutralized with saturated aqueous NaHCO 3 solution and filtered through a celite pad. The filtrate was extracted into CHCl 3 (30 ml), organic phase was separated, washed with brine, dried over anhydrous Na 2 SO 4 and the solvent was removed under reduced pressure to obtain a residue. 
1-[(    -D-Xylofuranosyloxy)methyl]uracil (11)
To a solution of 9 (0.8 g, 1.36 mmol) in methanol (15 mL) was added a catalytic amount of NaHCO 3 (0.1 g) and refluxed for 3 h. After completion of the reaction the reaction mixture was neutralized with IR 120 H + resin, filtered, washed with methanol (15 mL) and filtrate was evaporated to a residue. The residue was dissolved in water (30 mL) washed with chloroform (2x25 mL); the water phase was concentrated to isolate the title compound 11 as a thick syrup (0.32 g, 84%). 
1-[(
The benzoylated derivative 12 (0.8g, 1.33 mmol) in methanol (16 mL) was deprotected as described for 11 to isolate the title compound 14 as a white solid (0. 
The benzoylated derivative 15 (0.6 g, 0.9 mmol) was debenzoylated as described for 14 to isolate the title compound 17 as a syrup (0. 3.70 (1H, dd, J 5',5" = 12.8, J 4',5' = 5.0, H-5'), 3.84 (1H, dd, J 4',5" = 6.0, H-5"), 4.20 (1H, s, H-2'), 4.22-4.40 (2H, m, H-3', H-4'), 5.20 (1H, s, H-1'), 5.24, 5 .40 (2H, AB type quartet, J gem = 10.0, OCH 2 N), 6.20 (1H,d, J 5,6 = 7.8, H-5), 7.70 (1H, d, H-6) Anal. Calcd for C 10 H 15 O 6 N 2 : C, 43.95; H, 5.53; N, 15.38. Found: C, 44.11; H, 5.38; N, 15.21 . 5.80 (1H, d, J 3',4' = 3.5, H-3'), 5.84, 6 .02 (2H, AB type quartet, J gem = 9.8, OCH 2 N), 7. m, m, 
9-[(
The benzoyl derivative 25 (0.4g, 0.59 mmol) in methanol (10 mL) was deprotected as described for 11 to isolate the title compound 29 as a solid (0.14 g, 78%). H 15 O 6 N 5 : C, 42.17; H, 4.83; N, 22.36. Found: C, 42.31; H, 4.67; N, 23.43 .
7-[(    -D-Xylofuranosyloxy)methyl]guanine (30)
The benzoylated derivative 26 (0.2 g, 0.29 mmol) in methanol (6 mL) was deprotected as described for 11 to isolate the title compound 30 as a white solid (0.07 g, 75.0%). , 4.83; N, 22.36. Found: C, 42.25; H, 4.41; N, 22.62 .
CONCLUSION
In summary, we have successfully demonstrated that iterative glycosylation of acetoxymethoxy xylofuranosyl donor resulted in the formation of novel xylofuranosyloxymethyl nucleosides. The coupling reactions using SnCl 4 as an activator resulted in the formation of a mixture of natural nucleosides and novel xylofuranosyloxymethyl nucleosides whereas use of TMSOTf resulted in the exclusive formation of novel xylofuranosyloxymethyl nucleosides (in case of uracil, thymine, guanine) and mixture of nucleosides (in case of cytosine and adenine). The application of this new method to other glycosyl donors exploring various Lewis acids and their biological functions will be reported in near future.
